Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amoxicillin + vonoprazan dual therapy dosing and duration for Helicobacter pylori eradication
ChiCTR2000041477Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Nanchang University
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of vonoprazan and amoxicillin in Helicobacter pylori infection (4 arms), sponsored by First Affiliated Hospital of Nanchang University. Primary endpoint: Helicobacter pylori eradication rate. Started Jan 2021; status: recruiting.
02
Drugs
vonoprazanamoxicillin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR2000041477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000041477.